Vantage logo

A ternary outcome for Tocagen

Tocagen’s Toca-5 trial has survived two interim reviews, and faces final readout by the end of this year.

Vantage logo

Vantage ESC 2019 roundup

A collection of all of Vantage's coverage from the 2019 European Society of Cardiology meeting.

Vantage logo
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.